Home > Publications database > The Role of Cytomegalovirus in Prostate Cancer Incidence and Mortality. > print |
001 | 288741 | ||
005 | 20250814140816.0 | ||
024 | 7 | _ | |a 10.1016/j.euo.2024.02.004 |2 doi |
024 | 7 | _ | |a pmid:38418266 |2 pmid |
037 | _ | _ | |a DKFZ-2024-00444 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Classon, Johanna |b 0 |
245 | _ | _ | |a The Role of Cytomegalovirus in Prostate Cancer Incidence and Mortality. |
260 | _ | _ | |a Amsterdam |c 2024 |b Elsevier |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1730277214_11638 |2 PUB:(DE-HGF) |x Editorial |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a 2024 Oct;7(5):1144-1146 / or letter |
536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Britten, Abigail |b 1 |
700 | 1 | _ | |a Alkass, Kanar |b 2 |
700 | 1 | _ | |a Druid, Henrik |b 3 |
700 | 1 | _ | |a Brenner, Nicole |0 P:(DE-He78)b1326dc42cbbc5f92b10fe5f254f0bc2 |b 4 |u dkfz |
700 | 1 | _ | |a Waterboer, Tim |0 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30 |b 5 |u dkfz |
700 | 1 | _ | |a Wareham, Nicholas J |b 6 |
700 | 1 | _ | |a Gkrania-Klotsas, Effrossyni |b 7 |
700 | 1 | _ | |a Frisén, Jonas |b 8 |
773 | _ | _ | |a 10.1016/j.euo.2024.02.004 |g p. S2588931124000488 |0 PERI:(DE-600)2945338-0 |n 5 |p 1144-1146 |t European urology oncology |v 7 |y 2024 |x 2588-9311 |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/288741/files/1-s2.0-S2588931124000488-main.pdf |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/288741/files/1-s2.0-S2588931124000488-main.pdf?subformat=pdfa |x pdfa |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:288741 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)b1326dc42cbbc5f92b10fe5f254f0bc2 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR UROL ONCOL : 2022 |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-08-25 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-08-25 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b EUR UROL ONCOL : 2022 |d 2023-08-25 |
920 | 1 | _ | |0 I:(DE-He78)F020-20160331 |k F020 |l Infektionen und Krebs-Epidemiologie |x 0 |
920 | 1 | _ | |0 I:(DE-He78)D320-20160331 |k D320 |l Infektionen und Krebs-Epidemiologie |x 1 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)F020-20160331 |
980 | _ | _ | |a I:(DE-He78)D320-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|